Add to ORKGEqual contributors The advent of a miniaturized DNA sequencing device with a high-throughput contextual sequencing capability embodies the next generation of large scale sequencing tools. The MinION ™ Access Programme (MAP) was initiated by Oxford Nanopore Technologies ™ in April 2014, giving public access to their USB-attached miniature sequencing device. The MinION Analysis and Reference Consortium (MARC) was formed by a subset of MAP participants, with the aim of evaluating and providing standard protocols and reference data to the community. Envisaged as a multi-phased project, this study provides the global community with the Phase 1 data from MARC, where the reproducibility of the performance of the MinION was evaluated at multiple si...
AbstractThe Oxford Nanopore Technologies (ONT) MinION is a new sequencing technology that potentiall...
Nanopore technology provides a novel approach to DNA sequencing that yields long, label-free reads o...
Objectives: Genome sequencing will be increasingly used in the clinical setting to tailor antimicrob...
The advent of a miniaturized DNA sequencing device with a high-throughput contextual sequencing capa...
Journal ArticleCopyright © 2015 The Authors. Published by Elsevier GmbH.The Oxford Nanopore Technolo...
Long-read sequencing is rapidly evolving and reshaping the suite of opportunities for genomic analys...
Oxford Nanopore's third-generation, single-molecule sequencing platform promises to decrease costs f...
In 2014, Oxford Nanopore Technologies (ONT) introduced an affordable and portable sequencer called M...
In 2014, Oxford Nanopore Technologies (ONT) introduced an affordable and portable sequencer called M...
Long‐read sequencing technologies are transforming our ability to assemble highly complex genomes. R...
AbstractThe revolution of genome sequencing is continuing after the successful second-generation seq...
The revolution of genome sequencing is continuing after the successful second-generation sequencing ...
OBJECTIVES: Genome sequencing will be increasingly used in the clinical setting to tailor antimicrob...
Nanopore sequencing was conceived in 1989 by Dave Deamer (UCSC). Over two decades of development fro...
Summary: MinIONQC provides rapid diagnostic plots and quality control data from one or more flowcell...
AbstractThe Oxford Nanopore Technologies (ONT) MinION is a new sequencing technology that potentiall...
Nanopore technology provides a novel approach to DNA sequencing that yields long, label-free reads o...
Objectives: Genome sequencing will be increasingly used in the clinical setting to tailor antimicrob...
The advent of a miniaturized DNA sequencing device with a high-throughput contextual sequencing capa...
Journal ArticleCopyright © 2015 The Authors. Published by Elsevier GmbH.The Oxford Nanopore Technolo...
Long-read sequencing is rapidly evolving and reshaping the suite of opportunities for genomic analys...
Oxford Nanopore's third-generation, single-molecule sequencing platform promises to decrease costs f...
In 2014, Oxford Nanopore Technologies (ONT) introduced an affordable and portable sequencer called M...
In 2014, Oxford Nanopore Technologies (ONT) introduced an affordable and portable sequencer called M...
Long‐read sequencing technologies are transforming our ability to assemble highly complex genomes. R...
AbstractThe revolution of genome sequencing is continuing after the successful second-generation seq...
The revolution of genome sequencing is continuing after the successful second-generation sequencing ...
OBJECTIVES: Genome sequencing will be increasingly used in the clinical setting to tailor antimicrob...
Nanopore sequencing was conceived in 1989 by Dave Deamer (UCSC). Over two decades of development fro...
Summary: MinIONQC provides rapid diagnostic plots and quality control data from one or more flowcell...
AbstractThe Oxford Nanopore Technologies (ONT) MinION is a new sequencing technology that potentiall...
Nanopore technology provides a novel approach to DNA sequencing that yields long, label-free reads o...
Objectives: Genome sequencing will be increasingly used in the clinical setting to tailor antimicrob...
